Transcriptional activation of PIK3R1 by PPARγ in adipocytes

被引:0
|
作者
Yoon-Jin Kim
Hyun-Ji Kim
Ki Yong Chung
Inho Choi
Sang Hoon Kim
机构
[1] Kyung Hee University,Department of Biology, Research Institute for Basic Science
[2] National Institute of Animal Science,Hanwoo Experiment Station
[3] RDA,School of Biotechnology and Bovine Genome Resources Bank
[4] Yeungnam University,undefined
来源
Molecular Biology Reports | 2014年 / 41卷
关键词
Phosphatidylinositol 3-kinase regulatory subunit 1 (PIK3R1); Adipogenesis; Insulin; Peroxisome proliferator-activated receptor gamma (PPARγ); 3T3-L1 cells;
D O I
暂无
中图分类号
学科分类号
摘要
Phosphatidylinositol 3-kinase (PI3K) plays an important role in the metabolic actions of insulin and is required for adipogenesis. Regulatory subunit 1 of PI3K (PIK3R1) is a critical component of the PI3K signaling pathway. Peroxisome proliferator-activated receptor gamma (PPARγ) is a key regulator of adipogenesis. Although the PPARγ agonist rosiglitazone induces the expression of PIK3R1, the transcriptional regulation of PIK3R1 in adipocytes remains unknown. In this study, we investigated whether PIK3R1 is a direct target of PPARγ. The level of PIK3R1 expression in 3T3-L1 cells was increased after the induction of adipocyte differentiation and was also induced by overexpression of PPARγ. Furthermore, the upregulation of PPARγ-mediated PIK3R1 expression enhanced the insulin-stimulated AKT activation in 3T3-L1 cells. Two putative peroxisome proliferator response elements (PPREs) in the PIK3R1 promoter were identified as PPARγ binding sites. By chromatin immunoprecipitation, we observed that PPARγ interacts with the two PPRE regions of the PIK3R1 promoter in mature adipocytes. In addition, luciferase reporter assays showed that the −1183/−1161 and −573/−551 regions of the PIK3R1 promoter contain essential elements for PPARγ binding. Taken together, these results suggest that PPARγ is essential for the transcriptional activity of PIK3R1 during adipogenesis.
引用
收藏
页码:5267 / 5272
页数:5
相关论文
共 50 条
  • [31] The Opposing Roles of PIK3R1/p85α and PIK3R2/p85β in Cancer
    Vallejo-Diaz, Jesus
    Chagoyen, Monica
    Olazabal-Moran, Manuel
    Gonzalez-Garcia, Ana
    Clara Carrera, Ana
    TRENDS IN CANCER, 2019, 5 (04): : 233 - 244
  • [32] Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment
    Cheung, Lydia W. T.
    Mills, Gordon B.
    PHARMACOGENOMICS, 2016, 17 (03) : 297 - 307
  • [33] Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells
    Weber, Genevieve L.
    Parat, Marie-Odile
    Binder, Zev A.
    Gallia, Gary L.
    Riggins, Gregory J.
    ONCOTARGET, 2011, 2 (11) : 833 - 849
  • [34] PIK3R1 gene alterations, insights on its role in lung cancer
    Bonastre, Ester
    Pros, Eva
    Cespedes, Montserrat Sanchez
    CANCER RESEARCH, 2012, 72
  • [35] Clinical and functional assessment of a novel PIK3R1 variant in a patient with immunodeficiency
    Lichtenberger, Frank
    Suez, Daniel
    CLINICAL IMMUNOLOGY, 2024, 262
  • [36] Frequent PIK3R1 somatic mutations in cancer promotes survival signaling
    Jaiswal, Bijay
    Janakiraman, Vasant
    Seshagiri, Somasekar
    CANCER RESEARCH, 2009, 69
  • [37] Somatic mutation of PIK3R1 gene is rare in common human cancers
    Park, Sang Wook
    Kang, Mi Ran
    Eom, Hyeon Seok
    Han, Ji Youn
    Ahn, Chang Hyeok
    Kim, Sung Soo
    Lee, Sug Hyung
    Yoo, Nam Jin
    ACTA ONCOLOGICA, 2010, 49 (01) : 128 - 130
  • [38] Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1
    Dornan, Gillian L.
    Siempelkamp, Braden D.
    Jenkins, Meredith L.
    Vadas, Oscar
    Lucas, Carrie L.
    Burke, John E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (08) : 1982 - 1987
  • [39] Regulation of PPARγ transcriptional activity in 3T3-L1 adipocytes
    Watanabe, M
    Inukai, K
    Katagiri, H
    Awata, T
    Oka, Y
    Katayama, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (02) : 429 - 436
  • [40] PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy
    Tharin, Zoe
    Richard, Corentin
    Derangere, Valentin
    Ilie, Alis
    Arnould, Laurent
    Ghiringhelli, Francois
    Boidot, Romain
    Ladoire, Sylvain
    SCIENTIFIC REPORTS, 2023, 13 (01)